Skip to content
Optionomics

IIPR earnings analysis

10-Q · Filed November 3, 2026 · Our reading of the company's report

The latest report

IIP reported a solid Q3 2026 revenue and AFFO-per-share beat, with revenue of $64.743 million and AFFO per share of $1.96 versus consensus of $61.581 million and $1.65, respectively. Revenue improved sequentially but…

Read full summary

IIP reported a solid Q3 2026 revenue and AFFO-per-share beat, with revenue of $64.743 million and AFFO per share of $1.96 versus consensus of $61.581 million and $1.65, respectively. Revenue improved sequentially but was modestly below the prior-year quarter, while current-quarter gross margin, operating margin, free cash flow and segment results were not disclosed in the supplied 10-Q text. The principal negative is the growing IQHQ concentration: funded investments totaled approximately $411.0 million, or 16% of total assets, with $134.0 million of additional commitments still unfunded; no quantitative forward guidance was provided.

Read the original on SEC.gov

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Feb 2024 Nov 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

Reported figures

Earnings per share
$1.96

What stood out

  • Revenue beat estimates

    Third-quarter revenue was $64.743 million, up approximately 2.8% from $63 million in Q2 2026 but down approximately 0.4% from $65 million in Q3 2025. Revenue exceeded the $61.581 million consensus estimate by approximately 5.1%.

  • Strong AFFO-per-share growth

    Reported AFFO per share was $1.96 versus the $1.65 consensus estimate, a 18.8% beat. The $1.96 result increased from $1.36 in Q2 2026 and $0.97 in Q3 2025.

  • Expanded life-science investments

    The company increased its aggregate funded investment in IQHQ and affiliates to approximately $411.0 million as of September 30, 2026, including a $100.0 million IQHQ Credit Facility investment and approximately $111.0 million under the IQHQ Alewife Mezzanine Loan.

  • Additional investment capacity

    The company had approximately $245.0 million of additional commitments under the IQHQ Alewife Mezzanine Loan, of which approximately $134.0 million remained unfunded as of September 30, 2026.

  • Controls remained effective

    Disclosure controls and procedures were deemed effective as of September 30, 2026, and management reported no changes in internal control over financial reporting that materially affected, or were reasonably likely to materially affect, those controls.

What to watch

  • Material IQHQ concentration

    IQHQ and affiliates represented approximately 16% of total assets, with an aggregate funded investment of approximately $411.0 million as of September 30, 2026. A default or deterioration at IQHQ could adversely affect multiple investments, liquidity, borrowing capacity and distributions.

  • Subordinated IQHQ collateral

    Approximately $134.0 million of the $245.0 million IQHQ Alewife Mezzanine Loan commitment remained unfunded, and the timing of advances was not within the company's control. The loan is secured only by pledged equity interests that are structurally subordinate to the senior mortgage loan, limiting potential recovery.

  • Variable-rate exposure

    A 1% change in interest rates would change annual interest expense by $2.4 million based on September 30, 2026 variable-rate debt. The company also had approximately $111.0 million outstanding under its portion of the IQHQ Alewife Mezzanine Loan, creating exposure to funding-cost and investment-spread pressure.

  • REIT qualification risk

    The company stated that its $100.0 million IQHQ Credit Facility investment may not qualify as a REIT real-estate asset or qualifying income, while the approximately $111.0 million Alewife Mezzanine Loan relies on IRS Revenue Procedure 2003-65 safe-harbor treatment. A successful challenge could affect REIT qualification.

Management's outlook

No forward revenue or EPS guidance was provided; the 10-Q does not establish quantitative operating guidance.

Earlier filings 4

10-Q · August 4, 2026

IIPR reported Q2 revenue of $63.315 million, down 8.2% sequentially but roughly flat year over year, while GAAP diluted EPS increased to $1.36 from $0.86 a year earlier, supported by an $11.847 million net property-sale…

10-Q · May 5, 2026

Innovative Industrial Properties, Inc. reported Q1 2026 with revenues of $68.9 million and EPS of $1.88, marking a year-over-year decline in revenue but an increase in EPS compared to the prior period. Management…

10-K · February 24, 2026

Innovative Industrial Properties (IIPR) reports a portfolio-driven REIT strategy focused on sale-leaseback cannabis properties while adding life-science investments in 2025 (IQHQ preferred and credit). Portfolio scale…

10-Q · May 8, 2025

Innovative Industrial Properties reported total revenues of $71,722 (in thousands) and net income of $31,077 (in thousands) for the three months ended March 31, 2025. Revenue and operating income declined versus the…

Smart money in IIPR

Totals from the last full session. Insider and politician figures cover 90 days.

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.

See every IIPR trade live.

The free pages stop at the last full session. Trader shows every trade as it prints.

Start tracking No card needed.